Godolphin W - Search Results

1

Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.

Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R, et al. Press MF, et al. Among authors: godolphin w. Cancer Res. 1993 Oct 15;53(20):4960-70. Cancer Res. 1993. PMID: 8104689

2

HER-2/neu oncogene amplification and expression in breast and ovarian cancers.

Press MF, Jones LA, Godolphin W, Edwards CL, Slamon DJ. Press MF, et al. Among authors: godolphin w. Prog Clin Biol Res. 1990;354A:209-21. Prog Clin Biol Res. 1990. PMID: 1978943 Review. No abstract available.

3

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

Press MF, Hung G, Godolphin W, Slamon DJ. Press MF, et al. Among authors: godolphin w. Cancer Res. 1994 May 15;54(10):2771-7. Cancer Res. 1994. PMID: 7909495

4

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.

Pauletti G, Godolphin W, Press MF, Slamon DJ. Pauletti G, et al. Among authors: godolphin w. Oncogene. 1996 Jul 4;13(1):63-72. Oncogene. 1996. PMID: 8700555

5

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, et al. Slamon DJ, et al. Among authors: godolphin w. Science. 1989 May 12;244(4905):707-12. doi: 10.1126/science.2470152. Science. 1989. PMID: 2470152

6

Survival with breast cancer: the importance of estrogen receptor quantity.

Shek LL, Godolphin W. Shek LL, et al. Among authors: godolphin w. Eur J Cancer Clin Oncol. 1989 Feb;25(2):243-50. doi: 10.1016/0277-5379(89)90015-1. Eur J Cancer Clin Oncol. 1989. PMID: 2702979

7

Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis.

Shek LL, Godolphin W. Shek LL, et al. Among authors: godolphin w. Cancer Res. 1988 Oct 1;48(19):5565-9. Cancer Res. 1988. PMID: 3416309

8

Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients.

Shek LL, Godolphin W, Spinelli JJ. Shek LL, et al. Among authors: godolphin w. Br J Cancer. 1987 Dec;56(6):825-9. doi: 10.1038/bjc.1987.298. Br J Cancer. 1987. PMID: 3435707 Free PMC article.

9

Relationship between variant forms of estrogen receptor RNA and an apoptosis-related RNA, TRPM-2, with survival in patients with breast cancer.

Rennie PS, Mawji NR, Coldman AJ, Godolphin W, Jones EC, Vielkind JR, Bruchovsky N. Rennie PS, et al. Among authors: godolphin w. Cancer. 1993 Dec 15;72(12):3648-54. doi: 10.1002/1097-0142(19931215)72:12<3648::aid-cncr2820721216>3.0.co;2-l. Cancer. 1993. PMID: 8252481

10

Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: a study of 583 patients.

Godolphin W, Elwood JM, Spinelli JJ. Godolphin W, et al. Int J Cancer. 1981 Dec;28(6):677-83. doi: 10.1002/ijc.2910280604. Int J Cancer. 1981. PMID: 7333702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters